Startseite/Aktien/SXTP

SXTP

USD

60 Degrees Pharmaceuticals Inc. Common Stock

$1.230+0.000 (0.000%)

Echtzeitkurs

Healthcare

Biotechnologie

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.230

Hoch

$1.269

Tief

$1.180

Volumen

0.12M

Unternehmensfundamentaldaten

Marktkapitalisierung

5.0M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.14M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $1.18Aktuell $1.230Hoch $12.45

Ähnliche Nachrichten

15. Okt. 2025 · 11:14

GlobeNewswire

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

Breakthrough Therapy Designation request has been submitted to FDACompany to request a Type B meeting with FDA in early 2026 to discuss requirements for a supplementary New Drug Application (sNDA)Results obtained using

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

9. Okt. 2025 · 11:04

GlobeNewswire

60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study

Company engaged patients diagnosed with chronic babesiosis via social media in a nationwide naming competitionA $5K donation from the Company was split between ILADEF and GLA to recognize the winning nameB-FREE, a Phase